TY - JOUR
KW - Adult
KW - COVID-19/epidemiology
KW - Communicable Disease Control/organization & administration
KW - Comorbidity
KW - Female
KW - Humans
KW - Male
KW - Methadone/administration & dosage/therapeutic use
KW - Middle Aged
KW - New York City/epidemiology
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/drug therapy
KW - Pandemics
KW - Program Evaluation
KW - SARS-CoV-2
KW - Telemedicine/organization & administration
AU - A. Harocopos
AU - M. L. Nolan
AU - G. P. Goldstein
AU - S. Mantha
AU - M. O'Neill
AU - D. Paone
A1 - 
AB - Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation of fentanyl, ensuring continuity of methadone treatment during the COVID-19 pandemic is a vital public health priority. (Am J Public Health. 2021;111(12):2115-2117. https://doi.org/10.2105/AJPH.2021.306523).
AD - All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.; All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.; All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.; All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.; All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.; All authors are with the Bureau of Alcohol and Drug Use Prevention, Care, and Treatment, New York City Department of Health and Mental Hygiene, Queens, NY.
BT - American Journal of Public Health
C5 - Opioids & Substance Use
CP - 12
DO - 10.2105/AJPH.2021.306523
IS - 12
JF - American Journal of Public Health
LA - eng
M1 - Journal Article
N2 - Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation of fentanyl, ensuring continuity of methadone treatment during the COVID-19 pandemic is a vital public health priority. (Am J Public Health. 2021;111(12):2115-2117. https://doi.org/10.2105/AJPH.2021.306523).
PY - 2021
SN - 1541-0048; 0090-0036; 0090-0036
SP - 2115
EP - 2117
EP - 
T1 - Implementing a Methadone Delivery System in New York City in Response to COVID-19
T2 - American Journal of Public Health
TI - Implementing a Methadone Delivery System in New York City in Response to COVID-19
U1 - Opioids & Substance Use
U2 - 34878865
U3 - 10.2105/AJPH.2021.306523
VL - 111
VO - 1541-0048; 0090-0036; 0090-0036
Y1 - 2021
Y2 - Dec
ER -